• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
192.89 -3 (-1.77%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    191.31
  • Today’s High

    196.25
  • Open

    194.55
  • Perv Close

    196.36
  • 52W Low

    155.00
  • 52W High

    369.70

Key Indicators

  • P/E(TTM)

    27.70

  • Mar.Cap (₹Cr.)

    931.38

  • Div & Yield %

    1.56

  • Book Value(₹)

    85.82

  • Debt-Equity Ratio

    -1.77

  • AGM Date

    30-Apr-2025

  • EPS

    6.95

  • P/E Ratio

    27.70

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    931.38

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.29

  • BV (₹)

    85.80

  • Sales( ₹ in Cr.)

    337.46

  • NP (in Cr.)

    34.64

  • NP Var(%)

    11.0

  • Div%

    30.0

  • CPS (₹)

    8.10

  • EPS (₹)

    7.20

  • Traded Value (₹ in Lakhs)

    947.36

  • 52 Week High

    369.70

  • 52 Week Low

    155.00

  • Price BSE

    196.0

  • Price NSE

    196.00

  • Market Capital( in Cr.)

    947.36

  • P/C Ratio

    24.10

  • P/E Ratio

    27.30

  • Price Vs.BV

    7.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 337.46 273.09 204.52 222.83 179.29 196.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 337.46 273.09 204.52 222.83 179.29 196.65
Other Income 16.71 16.09 8.03 10.41 1.99 3.10
Stock Adjustments 1.74 -3.55 3.93 -14.70 17.33 -0.47
Total Income 355.91 285.63 216.48 218.54 198.61 199.28
EXPENDITURE :            
Raw Materials 231.89 174.14 131.75 123.04 118.50 116.89
Power and Fuel Cost 7.89 7.58 6.51 5.68 6.21 6.30
Employee Cost 25.61 25.15 21.05 18.34 20.02 20.38
Other Manufacturing Expenses 12.45 10.69 9.75 8.33 7.28 8.89
Selling and Administration Expenses 22.45 20.85 22.65 19.79 19.54 19.32
Miscellaneous Expenses 1.98 3.23 1.31 2.75 1.90 1.57
Employee Benefit Expenses 25.61 25.15 21.05 18.34 20.02 20.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 302.26 241.63 193.03 177.93 173.45 173.35
Operating Profit 53.64 44.00 23.44 40.62 25.16 25.92
Interest 4.50 2.67 2.95 3.81 5.96 5.46
Gross Profit 49.14 41.33 20.49 36.81 19.20 20.46
Depreciation 4.62 4.41 4.32 4.10 3.47 3.11
Profit Before Tax 44.52 36.92 16.17 32.71 15.73 17.35
Current Tax 10.08 5.87 3.75 5.76 2.80 3.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 -0.21 0.67 3.48 1.71 0.91
Reported Net Profit 34.64 31.25 11.74 23.47 11.22 12.97
Extraordinary Items 0.00 0.00 0.00 -0.01 -0.04 -0.04
Adjusted Net Profit 34.64 31.25 11.74 23.48 11.26 13.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.07
P & L Balance brought forward 79.20 62.41 57.15 40.17 28.95 16.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.46 14.46 6.49 6.49 0.00 0.00
P & L Balance carried down 99.38 79.20 62.41 57.15 40.17 28.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 0.00 0.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 0.00 0.00
Earnings Per Share-Unit Curr 7.18 6.48 2.44 5.43 2.59 3.00
Earnings Per Share(Adj)-Unit Curr 7.18 6.48 2.44 5.43 2.59 3.00
Book Value 86.47 82.05 78.56 57.07 53.10 50.51
Book Value(Adj)-Unit Curr 86.47 82.05 78.56 57.07 53.10 50.51

Shareholding Pattern

  • Promoter Group

    44.42%

  • Public Share Holding

    55.58%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 16,035,193 33.21 16,035,193 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,414,010 11.21 5,414,010 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,449,203 44.42 21,449,203 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 300 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 540,733 1.12 540,733 28
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,482 0.00 982 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 543,115 1.12 542,015 40
2] Non Institution
Bodies Corporate 3,095,900 6.41 3,076,300 318
Clearing Members 96,534 0.20 96,534 25
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,892,805 3.92 1,892,655 877
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,234,799 2.56 1,234,799 1,261
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,918,570 8.12 3,918,570 70
Individuals holding nominal share capital up to Rs. 1 lakh 16,050,731 33.24 15,811,483 56,039
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 26,292,787 54.45 26,033,789 58,593
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 500 0.00 500 1
Total Shares held by Custodians and against which Depository Receipts have been issued 500 0.00 500 1
Grand Total ( A + B + C ) 48,285,605 100.00 48,025,507 58,652

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010
  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Susheel Somani

  • Managing Director

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 192.50 354.17 337.46 27.70 11.24
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92